Rate Chat Website customer support, powered by txt.me

TrialPal
ePRO/eCOA

Request a Demo

TrialPal
ePRO/eCOA

Request a Demo

Best combined with:

TrialPal
ePRO/eCOA

Our eCOA/ePRO Decentralized Clinical Trial (DCT) mobile and web application is an intuitive and easy-to-use web application tool that allows the monitoring of trial participants and the study in general through dashboards, combined with a user-friendly app created to generate data directly from the trial participants.

Benefits of TrialPal

Feature One

Reliable

Feature Two

Real-time information

Feature Three

Configurable

Feature Four

User-friendly

Feature Five

Offline functions

Feature Six

Traceability

Feature Seven

Works in Mobile and Web devices

TrialPal Mobile

TrialPal
New Features

Create eDiaries and any other trial-specific forms in as little as 1-2 hours as per protocol specifications.
Dual data entry options for participants.
Customize notifications to participants by study and user.
To activate additional modules such as Chat, eConsent, and Telehealth (Beta version). A way to enable hybrid or decentralized clinical trials (DCT) when integrating TrialPal with Trial360 and EDC.
To enhance interoperability between site CTMS, EDCs, or any third-party application.
Reduce implementation and operational costs.

Value
Add Services

  • Real-time Executive Descriptive Analytics and Dashboards
  • End to End Integrations
  • Real-Time notifications
  • On Site Patient Engagement and Site support
    • LA Footprint – Local Presence
    • Combined with Online and Self Support, and Remote Control
    • Subject Trial Pal training and follow-up
  • Customizable site reports
  • On site and remote frequent training
  • Cell-phone inventory management
  • Internet data prepaid plans management

TrialPal Modules

Success
Stories

We studied the performance of a smartphone application-based participatory syndromic surveillance (PSS) system for collecting syndromic data (acute febrile illness [AFI] and acute gastroenteritis [AGE]) to detect dengue virus (DENV) and norovirus (NoV) on a cohort of children living in a low-resource and rural area of Guatemala.

 

  • 469 Participants
  • 207 Households
  • 322 Participants >68% response rate during the study (April 2015 – June 2016)

Read the entire article “Performance of a Smartphone Application-Based Participatory Syndromic Surveillance System for Acute Febrile Illness and Acute Gastroenteritis in Rural Guatemala” by D. Olson, Takeda Pharmaceuticals: Consultant, Grant recipient. R. Zambrano, Integra IT: Employee and Shareholder, Salary. S. Rodriguez-Castro, Integra IT: Employee and Shareholder, Salary. E. J. Asturias, Takeda Pharmaceuticals: Consultant and Grant Investigator, Grant recipient, at Oxford Academic here: https://academic.oup.com/ofid/article/4/suppl_1/S162/4294083?login=true

Smartphone performance on studies
Fe vs Blood sample collection

FE known by site vs Blood sample collection

  • 77% of samples were collected in the first 2 days.
  • 88% of samples were collected in the window.

Clinical Trial: 935 subjects
Phase 2 Dengue Vaccine
Site: Cevaxin Panama

Want to know more about our TrialPal ePRO/eCOA + Site CTMS?

Schedule a meeting with us!

TrialPal PFS